Back to Search Start Over

Dose-dense therapy with non-pegylated liposomal doxorubicin (R-comp 14 vs. 21) is feasible and effective for elderly patients with newly diagnosed aggresive B-cell non-Hodgkin lymphoma

Tools

Authors Abstract Subjects Details